Displacement analysis of the October 30, 2020 (Mw = 6.9), Samos (Aegean Sea) earthquake by Çırmık A., Ankaya Pamukçu O., Doğru F., Cingöz A., Özdağ Ö. C., Sözbilir H.

Get full text

High Brightness XUV Frequency Combs via Intracavity High Harmonic Generation by Ruehl A., Fermann M., Yost D. C., Benko C., Cingöz A., Allison T. K., Hartl I., Ye J.

Get full text

Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer by Saraç, H, Morova, T, Pires, E, McCullagh, J, Kaplan, A, Cingöz, A, Bagci-Onder, T, Önder, T, Kawamura, A, Lack, NA

The fungal metabolite chaetocin is a sensitizer for pro-apoptotic therapies in glioblastoma by Ozyerli-Goknar, E, Sur-Erdem, I, Seker, F, Cingöz, A, Kayabolen, A, Kahya, Z, Uyulur, F, Gezen, M, Tolay, N, Erman, B, Gönen, M, Dunford, J, Oppermann, U, Bagci-Onder, T

EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities by Yedier-Bayram, O, Gokbayrak, B, Kayabolen, A, Aksu, AC, Cavga, AD, Cingöz, A, Kala, EY, Karabiyik, G, Günsay, R, Esin, B, Morova, T, Uyulur, F, Syed, H, Philpott, M, Cribbs, AP, Kung, SHY, Lack, NA, Onder, TT, Bagci-Onder, T

Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival by Ozyerli-Goknar, E, Kala, EY, Aksu, AC, Bulut, I, Cingöz, A, Nizamuddin, S, Biniossek, M, Seker-Polat, F, Morova, T, Aztekin, C, Kung, SHY, Syed, H, Tuncbag, N, Gönen, M, Philpott, M, Cribbs, AP, Acilan, C, Lack, NA, Onder, TT, Timmers, HTM, Bagci-Onder, T